Tourmaline Bio Statistics
Total Valuation
Tourmaline Bio has a market cap or net worth of $542.85 million. The enterprise value is $264.04 million.
Important Dates
The last earnings date was Thursday, November 7, 2024, before market open.
| Earnings Date | Nov 7, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Tourmaline Bio has 25.64 million shares outstanding. The number of shares has increased by 16.90% in one year.
| Current Share Class | 25.64M |
| Shares Outstanding | 25.64M |
| Shares Change (YoY) | +16.90% |
| Shares Change (QoQ) | +0.17% |
| Owned by Insiders (%) | 8.45% |
| Owned by Institutions (%) | 53.61% |
| Float | 12.73M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 1.62 |
| P/TBV Ratio | 1.70 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 40.33, with a Debt / Equity ratio of 0.00.
| Current Ratio | 40.33 |
| Quick Ratio | 38.70 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -31.82% and return on invested capital (ROIC) is -24.50%.
| Return on Equity (ROE) | -31.82% |
| Return on Assets (ROA) | -23.82% |
| Return on Capital (ROIC) | -24.50% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.45M |
| Employee Count | 44 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +7.05% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +7.05% |
| 50-Day Moving Average | 25.55 |
| 200-Day Moving Average | 20.60 |
| Relative Strength Index (RSI) | 34.60 |
| Average Volume (20 Days) | 182,787 |
Short Selling Information
The latest short interest is 1.63 million, so 6.38% of the outstanding shares have been sold short.
| Short Interest | 1.63M |
| Short Previous Month | 1.66M |
| Short % of Shares Out | 6.38% |
| Short % of Float | 12.84% |
| Short Ratio (days to cover) | 8.15 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -78.82M |
| Pretax Income | -35.69M |
| Net Income | -63.88M |
| EBITDA | -78.78M |
| EBIT | -78.82M |
| Earnings Per Share (EPS) | -$2.79 |
Full Income StatementBalance Sheet
The company has $281.92 million in cash and $290,000 in debt, giving a net cash position of $281.63 million or $10.98 per share.
| Cash & Cash Equivalents | 281.92M |
| Total Debt | 290,000 |
| Net Cash | 281.63M |
| Net Cash Per Share | $10.98 |
| Equity (Book Value) | 321.07M |
| Book Value Per Share | 12.52 |
| Working Capital | 286.50M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$65.73 million and capital expenditures -$2,000, giving a free cash flow of -$65.73 million.
| Operating Cash Flow | -65.73M |
| Capital Expenditures | -2,000 |
| Free Cash Flow | -65.73M |
| FCF Per Share | -$2.56 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |